Tag: Drug Approvals
Promacta Approval Expanded for Children With Chronic ITP
Builds on recent approval for ages 6 years and up for chronic immune thrombocytopenic purpura
FDA Approves Libido Pill for Women
Addyi to treat generalized hypoactive sexual desire disorder among premenopausal women
FDA Approves Balloon Device to Treat Obesity
Inflated in stomach, it may create sense of fullness
FDA Approves Praluent for Certain Cases of High Cholesterol
First in a new class of injectable cholesterol-lowering medications
FDA Approves Test to Differentiate HIV Viruses
Among people two years and older
FDA Approves Technivie for Hepatitis C
For people with chronic hepatitis C genotype 4
FDA Approves Odomzo for Recurring Basal Cell Carcinoma
Medication is designed to inhibit the Hedgehog pathway
FDA Approves Novel Leg Prosthesis for AKAs
New device adheres to the leg with fixtures and screws implanted into the remaining thigh bone
FDA Approves Rexulti for Schizophrenia, Depression
But shouldn't be prescribed to some older people
![Iressa (gefitinib) has been approved by the U.S. Food and Drug Administration to treat patients with metastatic non-small-cell lung cancer with a specific genetic mutation (epidermal growth factor receptor [EGFR]). A just-approved companion diagnostic test can identify patients who could benefit from this new use.](https://www.ehealth-news.com/wp-content/uploads/2016/01/fdalogo-6-180x84.jpg "FDA Approves Iressa for EGFR+ Metastatic Lung Cancer")
FDA Approves Iressa for EGFR+ Metastatic Lung Cancer
New companion diagnostic kit can identify candidates
